Related Experiment Video

Updated: Jun 9, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Upstream treatment of acute coronary syndrome in the ED

J Douglas Kirk1, Michael Kontos, Deborah B Diercks

  • 1Department of Emergency Medicine, University of California, Davis, Medical Center, Sacramento, CA 95817, USA. jdkirk@ucdavis.edu

The American Journal of Emergency Medicine
|September 10, 2010
PubMed

Insights

Optimal care for acute coronary syndromes (ACS) involves rapid risk assessment and tailored pharmacotherapy. Simplified management strategies can improve patient outcomes by streamlining medication selection for emergency department patients.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute coronary syndromes (ACS) require prompt management in emergency departments.
  • Pharmacotherapy selection is critical for optimizing patient outcomes.
  • Current antiplatelet and antithrombotic options have specific limitations.

Purpose of the Study:

  • To review pharmacotherapy options for acute coronary syndromes.
  • To highlight challenges with current antiplatelet and antithrombotic agents.
  • To emphasize the need for simplified management paradigms.

Main Methods:

  • Review of available antiplatelet and antithrombotic medications.
  • Discussion of limitations of thienopyridines (clopidogrel, prasugrel) and glycoprotein IIb-IIIa inhibitors.
  • Consideration of bivalirudin as an alternative agent.

Main Results:

  • Thienopyridines exhibit response variability and increased bleeding risk, especially before coronary artery bypass graft surgery.
  • Glycoprotein IIb-IIIa inhibitors are effective but require careful use to mitigate bleeding risk.
  • Bivalirudin is a direct thrombin inhibitor with cost and indication limitations.

Conclusions:

  • Tailoring pharmacotherapy to patient risk status is essential for ACS care.
  • Existing medications present challenges requiring careful consideration.
  • Simplified institutional management paradigms can enhance care delivery and patient outcomes.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...